Production (Stage)
Utah Medical Products, Inc.
UTMD
$53.76
$0.100.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -14.37% | -25.74% | -19.99% | -19.17% | -9.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.37% | -25.74% | -19.99% | -19.17% | -9.42% |
| Cost of Revenue | -8.79% | -26.74% | -18.32% | -19.11% | -2.20% |
| Gross Profit | -18.15% | -25.01% | -21.16% | -19.20% | -13.73% |
| SG&A Expenses | 2.73% | -17.59% | -36.30% | -33.64% | -34.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.90% | -23.78% | -24.03% | -22.47% | -12.59% |
| Operating Income | -25.18% | -29.04% | -12.22% | -13.43% | -4.41% |
| Income Before Tax | -19.59% | -27.96% | -12.59% | -18.58% | -6.27% |
| Income Tax Expenses | -2.97% | -2.60% | -27.19% | -22.02% | -6.96% |
| Earnings from Continuing Operations | -23.13% | -32.29% | -9.45% | -17.79% | -6.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.13% | -32.29% | -9.45% | -17.79% | -6.12% |
| EBIT | -25.18% | -29.04% | -12.22% | -13.43% | -4.41% |
| EBITDA | -21.25% | -29.24% | -25.90% | -26.53% | -19.64% |
| EPS Basic | -15.98% | -27.41% | -5.52% | -15.54% | -5.86% |
| Normalized Basic EPS | -17.82% | -25.39% | -5.89% | -8.69% | 0.66% |
| EPS Diluted | -15.95% | -27.47% | -5.56% | -14.97% | -5.69% |
| Normalized Diluted EPS | -17.82% | -25.39% | -5.63% | -8.42% | 0.88% |
| Average Basic Shares Outstanding | -8.51% | -6.72% | -4.17% | -2.66% | -0.28% |
| Average Diluted Shares Outstanding | -8.51% | -6.72% | -4.42% | -2.94% | -0.50% |
| Dividend Per Share | 1.67% | 1.67% | 1.69% | 1.69% | 1.69% |
| Payout Ratio | 0.21% | 0.43% | 0.08% | 0.23% | 0.08% |